Crossmark

The comparative efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists on metabolic benefits in T2DM patients: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s40001-026-03986-w

Published Online: 2026-01-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tong, Jingkai

Li, Nana

Hu, Fang

Yue, Yingying
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82202802)
License Information

Text and Data Mining valid from 2026-01-31

Version of Record valid from 2026-03-02
More Information

Article History

Received: 27 August 2025

Accepted: 24 January 2026

First Online: 31 January 2026

Declarations

:

: Not applicable.

: All authors agree to publish.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below